Emmessar Biotech Financials

BSE: 524768

₹24.72

₹0.95 (4.00%)

As on 07-Sep-2026IST

Market cap

₹12 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

31.5

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	0.34	0.61	0.56	1.02	0.36	6.99
Total Income	2.38	2.62	2.55	2.77	2.28	8.46
Total Expenditure	1.77	1.56	1.64	1.71	1.26	6.14
EBITDA	-1.43	-0.95	-1.08	-0.69	-0.89	0.85
Depreciation	0.10	0.10	0.10	0.09	0.09	0.06
EBIT	-1.53	-1.05	-1.18	-0.78	-0.99	0.79
Interest	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.04	2.01	1.99	1.75	1.92	1.47
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.51	0.96	0.81	0.97	0.93	2.25
Provision for Tax	0.12	0.64	0.06	0.46	0.46	0.80
Profit after Tax	0.39	0.32	0.75	0.50	0.48	1.45

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	8.12	7.71	7.40	6.66	6.17	5.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.03	1.04	0.84	0.86	0.44	0.16
Current Liabilities	0.39	0.67	0.53	0.57	0.99	1.63
Total Liabilities	9.53	9.42	8.77	8.09	7.87	8.03

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	1.72	1.81	1.91	2.01	2.07	1.87
Current Assets	7.81	7.60	6.86	6.08	5.52	5.62
Total Assets	9.53	9.42	8.77	8.09	7.87	8.03
Total Debt*	--	--	0.11	0.08	--	--
Net Current Assets	7.42	6.93	6.33	5.51	4.53	3.99
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.22	0.64	0.38	2.27	0.47
Cash Flow from Investing Activities	--	-0.23	-0.64	-0.55	-2.61	0.01
Cash from Financing Activities	--	0.00	--	--	--	--
Net Cash Inflow / Outflow	--	0.00	0.00	-0.17	-0.34	0.48

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	0.78	0.63	1.50	1.01	0.95	2.90
Cash EPS (₹)	0.78	0.83	1.70	1.20	1.14	3.02
Adjusted Book Value (₹)	16.50	15.43	14.82	13.34	12.35	11.41
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.45	1.29	0.75	4.54	0.94
Free Cash Flow per Share (₹)	--	0.14	2.17	0.14	4.04	-0.22

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	12.63	11.42	14.99	15.71	45.29
ROE (%)	4.87	4.19	10.66	7.85	8.01	29.10
ROA (%)	4.18	3.48	8.89	6.42	6.30	22.47
EBIT Margin (%)	-454.01	-171.48	-212.21	-76.78	-270.27	11.31
Net Margin (%)	16.48	12.07	29.43	18.19	20.82	17.14
Cash Profit Margin (%)	0.00	67.74	152.59	58.61	155.58	21.56

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-46.08	10.03	-45.53	179.31	-94.78	105.86
EBIT Growth (%)	-44.89	11.08	-50.57	20.66	-224.77	271.44
Net Profit Growth (%)	-2.00	-57.82	48.79	5.97	-67.21	92.35
EPS Growth (%)	-1.99	-57.82	48.79	5.98	-67.21	92.34
Book Value Growth (%)	--	4.13	11.07	8.03	8.21	33.74

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	31.51	48.02	19.81	24.59	28.90	5.07
Price / Book Value	1.50	1.97	2.01	1.86	2.23	1.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	8.27	7.85	9.63	6.86	8.93	2.11
Close Price (₹)	24.70	30.39	29.72	24.80	27.50	14.70
High Price (₹)	42.90	64.00	47.69	47.40	55.65	28.99
Low Price (₹)	18.42	27.25	21.10	18.50	14.45	9.80
Market Cap (₹ Cr)	12.35	15.18	14.85	12.39	13.74	7.34

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	0.01	0.01	--	--
Short term debt to equity ratio	--	--	0.01	0.01	--	--
Current Ratio	20.28	11.34	12.95	10.70	5.58	3.45
Quick Ratio	20.03	11.16	12.78	10.46	5.51	3.41
Interest Coverage	127.75	331.41	626.08	744.77	932.50	1,466.98

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	4.75	2.91	4.02	1.06	3.54	38.77
Asset Turnover	0.04	0.07	0.07	0.13	0.05	1.08
Receivable days	--	11.98	10.88	4.24	1,361.86	71.44
Inventory Days	--	63.60	74.06	36.60	67.75	31.75
Payable days	--	12.45	16.76	--	752.50	67.17
Cash Conversion Cycle	--	63.13	68.18	--	677.11	36.02

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.